[
  {
    "ts": "2026-01-13T10:24:00+00:00",
    "headline": "AbbVie Strikes a $100 Billion Deal With Trump. How the Drugmaker Will Dodge Tariffs.",
    "summary": "AbbVie  has agreed to cut some drug prices and invest $100 billion in the U.S. in exchange for an exemption from some tariffs.  The pharma company said in a statement late Monday that it had struck a deal with the Trump administration to lower Medicaid prices and pour the money into U.S. research and development.  AbbVie will also expand its direct-to-patient offerings of certain drugs on the government portal TrumpRx.",
    "url": "https://www.barrons.com/articles/abbvie-stock-trump-tariffs-deal-4f08ec87?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "1d0e3ef9-8bce-3c03-92ed-9f3f6b25fa5f",
      "content": {
        "id": "1d0e3ef9-8bce-3c03-92ed-9f3f6b25fa5f",
        "contentType": "STORY",
        "title": "AbbVie Strikes a $100 Billion Deal With Trump. How the Drugmaker Will Dodge Tariffs.",
        "description": "",
        "summary": "AbbVie  has agreed to cut some drug prices and invest $100 billion in the U.S. in exchange for an exemption from some tariffs.  The pharma company said in a statement late Monday that it had struck a deal with the Trump administration to lower Medicaid prices and pour the money into U.S. research and development.  AbbVie will also expand its direct-to-patient offerings of certain drugs on the government portal TrumpRx.",
        "pubDate": "2026-01-13T10:24:00Z",
        "displayTime": "2026-01-13T10:24:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1d0e3ef9-8bce-3c03-92ed-9f3f6b25fa5f/abbvie-strikes-a-100-billion.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/0a2845aa6b4185d51e8f8c6cc2b1e7a8",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uprYtz96.huIUAIJcxlT7w--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/0a2845aa6b4185d51e8f8c6cc2b1e7a8.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LhuGYFvbZhLBqQD88UWabQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/0a2845aa6b4185d51e8f8c6cc2b1e7a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/abbvie-stock-trump-tariffs-deal-4f08ec87?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T12:48:28+00:00",
    "headline": "Tempus AI (TEM) Soars 15% on $1.1-Billion Deal",
    "summary": "We recently published 10 Stocks With Crazy Gains. Tempus AI Inc. (NASDAQ:TEM) was one of the top performers on Monday. Tempus AI snapped a two-day losing streak on Monday, soaring by as much as 15 percent to $76.33 apiece, as investors took heart from a strong demand for its services, having bagged $1.1 billion in […]",
    "url": "https://finance.yahoo.com/news/tempus-ai-tem-soars-15-124828137.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "8cd6eab2-2b32-3342-b8c7-afc388628b1c",
      "content": {
        "id": "8cd6eab2-2b32-3342-b8c7-afc388628b1c",
        "contentType": "STORY",
        "title": "Tempus AI (TEM) Soars 15% on $1.1-Billion Deal",
        "description": "",
        "summary": "We recently published 10 Stocks With Crazy Gains. Tempus AI Inc. (NASDAQ:TEM) was one of the top performers on Monday. Tempus AI snapped a two-day losing streak on Monday, soaring by as much as 15 percent to $76.33 apiece, as investors took heart from a strong demand for its services, having bagged $1.1 billion in […]",
        "pubDate": "2026-01-13T12:48:28Z",
        "displayTime": "2026-01-13T12:48:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4edc292b1dcbd797c07f522ebf66f3cd",
          "originalWidth": 768,
          "originalHeight": 512,
          "caption": "Tempus AI (TEM) Soars 15% on $1.1-Billion Deal",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wpXHllSshAhvRjKQLWZ8dQ--~B/aD01MTI7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4edc292b1dcbd797c07f522ebf66f3cd.cf.webp",
              "width": 768,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/V0NnFlegXm2HaeSZe_vD3A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4edc292b1dcbd797c07f522ebf66f3cd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ai-tem-soars-15-124828137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/tempus-ai-tem-soars-15-124828137.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "TEM"
            },
            {
              "symbol": "DSKYF"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "GSK"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "WHWK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T11:53:00+00:00",
    "headline": "Health Care Roundup: Market Talk",
    "summary": "Find insight on Bristol-Myers Squibb, Pfizer, Johnson & Johnson and more in the latest Market Talks covering Health Care.",
    "url": "https://www.wsj.com/business/health-care-roundup-market-talk-ab91a0b0?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "d5f617d3-f057-3b8c-9ae7-8e2e48f7211e",
      "content": {
        "id": "d5f617d3-f057-3b8c-9ae7-8e2e48f7211e",
        "contentType": "STORY",
        "title": "Health Care Roundup: Market Talk",
        "description": "",
        "summary": "Find insight on Bristol-Myers Squibb, Pfizer, Johnson & Johnson and more in the latest Market Talks covering Health Care.",
        "pubDate": "2026-01-13T11:53:00Z",
        "displayTime": "2026-01-13T11:53:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d5f617d3-f057-3b8c-9ae7-8e2e48f7211e/health-care-roundup-market.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/bd45e130fb5d221ae0c46fc72b2041d5",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ARM0GrkFQuANPgLprIGrwA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/bd45e130fb5d221ae0c46fc72b2041d5.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AsLL0hd96VZM1Aq90rZ1Kg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/bd45e130fb5d221ae0c46fc72b2041d5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/business/health-care-roundup-market-talk-ab91a0b0?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T11:27:10+00:00",
    "headline": "Eli Lilly Stock Rises on $1 Billion AI Bet With Nvidia",
    "summary": "Nvidia Pushes Deeper Into Health Care With Major Eli Lilly Partnership",
    "url": "https://finance.yahoo.com/news/eli-lilly-stock-rises-1-112710258.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "ff7bea74-7833-31c2-9949-f2c66ab8b721",
      "content": {
        "id": "ff7bea74-7833-31c2-9949-f2c66ab8b721",
        "contentType": "STORY",
        "title": "Eli Lilly Stock Rises on $1 Billion AI Bet With Nvidia",
        "description": "",
        "summary": "Nvidia Pushes Deeper Into Health Care With Major Eli Lilly Partnership",
        "pubDate": "2026-01-13T11:27:10Z",
        "displayTime": "2026-01-13T11:27:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c",
          "originalWidth": 500,
          "originalHeight": 500,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8b14zxH4BANQFraIfqB7ug--~B/aD01MDA7dz01MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 500,
              "height": 500,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_oIKXponyFLhltsjvcwTQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d0b2925021ba921981c34cbf188ac66c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-stock-rises-1-112710258.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-stock-rises-1-112710258.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T14:15:00+00:00",
    "headline": "Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery",
    "summary": "Illumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery through AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of human disease biology to date.",
    "url": "https://finance.yahoo.com/news/illumina-introduces-billion-cell-atlas-141500418.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b51307e1-1bc0-33d1-8dc4-662456728aa9",
      "content": {
        "id": "b51307e1-1bc0-33d1-8dc4-662456728aa9",
        "contentType": "STORY",
        "title": "Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery",
        "description": "",
        "summary": "Illumina, Inc. (NASDAQ: ILMN) today introduced the world's largest genome-wide genetic perturbation dataset, being built to accelerate drug discovery through AI across the pharmaceutical ecosystem. The Illumina Billion Cell Atlas is the first tranche of its program to build a 5 billion cell atlas over three years, and will be the most comprehensive map of human disease biology to date.",
        "pubDate": "2026-01-13T14:15:00Z",
        "displayTime": "2026-01-13T14:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/5303c01dbf70dd6a5a3a65f64bcf2446",
          "originalWidth": 400,
          "originalHeight": 225,
          "caption": "Illumina introduces Billion Cell Atlas",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rCcVV0ZeIzUFY.SzuayEdA--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5303c01dbf70dd6a5a3a65f64bcf2446.cf.webp",
              "width": 400,
              "height": 225,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N5nx5mIqzTOKOGtiqvHoWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/5303c01dbf70dd6a5a3a65f64bcf2446.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/illumina-introduces-billion-cell-atlas-141500418.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/illumina-introduces-billion-cell-atlas-141500418.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ILMN"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T14:06:19+00:00",
    "headline": "Jim Cramer Says “I’m a Eli Lilly Guy” When Asked About Viking Therapeutics",
    "summary": "Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer discussed, along with recent market rotation. When a caller asked about the stock, here’s what Cramer had to say in response: “Okay, no, look, I’m a Eli Lilly guy, okay? I’m going to stick with it. If I’m going to do Viking, I’m going […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-says-m-eli-140619910.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "336d3ff3-872a-362b-a58e-5f83321f2ae9",
      "content": {
        "id": "336d3ff3-872a-362b-a58e-5f83321f2ae9",
        "contentType": "STORY",
        "title": "Jim Cramer Says “I’m a Eli Lilly Guy” When Asked About Viking Therapeutics",
        "description": "",
        "summary": "Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the stocks Jim Cramer discussed, along with recent market rotation. When a caller asked about the stock, here’s what Cramer had to say in response: “Okay, no, look, I’m a Eli Lilly guy, okay? I’m going to stick with it. If I’m going to do Viking, I’m going […]",
        "pubDate": "2026-01-13T14:06:19Z",
        "displayTime": "2026-01-13T14:06:19Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6",
          "originalWidth": 6538,
          "originalHeight": 4359,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RYQ.uW7wwp9a4kdxC.OBbQ--~B/aD00MzU5O3c9NjUzODthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6.cf.webp",
              "width": 6538,
              "height": 4359,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2i4a98C_B2YJXhctyiN1Vw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/92264ef32b70332cc4ea9283d978e1a6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-m-eli-140619910.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-m-eli-140619910.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VKTX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MTSR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T14:02:00+00:00",
    "headline": "Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026?",
    "summary": "The gap may be too hard to close in the next 12 months.",
    "url": "https://www.fool.com/investing/2026/01/13/can-novo-nordisk-eli-lilly-weight-loss-drug/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "afb38c42-8d93-3040-bcc8-b90fd1ac63c2",
      "content": {
        "id": "afb38c42-8d93-3040-bcc8-b90fd1ac63c2",
        "contentType": "STORY",
        "title": "Can Novo Nordisk Unseat Eli Lilly as the Weight Loss Drug Leader in 2026?",
        "description": "",
        "summary": "The gap may be too hard to close in the next 12 months.",
        "pubDate": "2026-01-13T14:02:00Z",
        "displayTime": "2026-01-13T14:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/5e3153ec5ac74b418ab77fc6594a4f3f",
          "originalWidth": 1400,
          "originalHeight": 934,
          "caption": "Patient self-administering a shot.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9yDCv4zJUud9xZo8LFfVcg--~B/aD05MzQ7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/5e3153ec5ac74b418ab77fc6594a4f3f.cf.webp",
              "width": 1400,
              "height": 934,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Y.pP.HOxFa02pgII477Zsw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/5e3153ec5ac74b418ab77fc6594a4f3f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/13/can-novo-nordisk-eli-lilly-weight-loss-drug/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-unseat-eli-lilly-140200691.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T15:35:00+00:00",
    "headline": "Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026?",
    "summary": "Both companies now aim to win in the oral weight loss drug market.",
    "url": "https://www.fool.com/investing/2026/01/13/eli-lilly-vs-novo-nordisk-which-to-dominate-2026/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "407e7c4b-08ab-3542-8337-5f457681601c",
      "content": {
        "id": "407e7c4b-08ab-3542-8337-5f457681601c",
        "contentType": "STORY",
        "title": "Eli Lilly vs Novo Nordisk: Which Company Will Dominate the Weight Loss Drug Market in 2026?",
        "description": "",
        "summary": "Both companies now aim to win in the oral weight loss drug market.",
        "pubDate": "2026-01-13T15:35:00Z",
        "displayTime": "2026-01-13T15:35:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/b62ad15540cde43919cefa3c5a74219d",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "An investor takes notes while studying something on a laptop.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/k8NxW3iiFRqnm9ZIJv_ujw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/b62ad15540cde43919cefa3c5a74219d.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Nnx3MZq6n9Xa.j3pQg_ong--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/b62ad15540cde43919cefa3c5a74219d.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/13/eli-lilly-vs-novo-nordisk-which-to-dominate-2026/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-vs-novo-nordisk-153500550.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T12:52:00+00:00",
    "headline": "What to Expect From Eli Lilly’s Q4 2025 Earnings Report",
    "summary": "Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its earnings to rise in double-digits.",
    "url": "https://www.barchart.com/story/news/37015541/what-to-expect-from-eli-lillys-q4-2025-earnings-report",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "4d021d9c-8aea-3351-a3f2-ff66e30eac4e",
      "content": {
        "id": "4d021d9c-8aea-3351-a3f2-ff66e30eac4e",
        "contentType": "STORY",
        "title": "What to Expect From Eli Lilly’s Q4 2025 Earnings Report",
        "description": "",
        "summary": "Eli Lilly is gearing up to announce its fiscal 2025 fourth-quarter earnings in the near term, and analysts project its earnings to rise in double-digits.",
        "pubDate": "2026-01-13T12:52:00Z",
        "displayTime": "2026-01-13T12:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/0d9ac77c949cf1810e20427fc62c5fa4",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Lilly(Eli) & Co logo on building-by Michael Vi via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rRoaSjcBmk5ZphUbBkOsTw--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/0d9ac77c949cf1810e20427fc62c5fa4.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/81k.kKF6ujx761TcDBUQuA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/0d9ac77c949cf1810e20427fc62c5fa4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/37015541/what-to-expect-from-eli-lillys-q4-2025-earnings-report",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/expect-eli-lilly-q4-2025-125200633.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T17:12:33+00:00",
    "headline": "Eli Lilly teams up with Nvidia on AI lab: CFO explains why",
    "summary": "Eli Lilly (LLY) is teaming up with Nvidia (NVDA) to invest in an artificial intelligence (AI) innovation lab. Eli Lilly CFO and executive vice president Lucas Montarce joins Market Catalysts host Julie Hyman to discuss how the pharmaceutical company is leveraging AI to expedite drug discovery. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
    "url": "https://finance.yahoo.com/video/eli-lilly-teams-nvidia-ai-171233886.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "40579326-6c3e-3a92-bb0d-a31905ddcd1c",
      "content": {
        "id": "40579326-6c3e-3a92-bb0d-a31905ddcd1c",
        "contentType": "VIDEO",
        "title": "Eli Lilly teams up with Nvidia on AI lab: CFO explains why",
        "description": "<p>Eli Lilly (<a data-i13n=\"cpos:1;pos:1\" href=\"https://finance.yahoo.com/quote/LLY\">LLY</a>) is teaming up with Nvidia (<a data-i13n=\"cpos:2;pos:1\" href=\"https://finance.yahoo.com/quote/NVDA\">NVDA</a>) to invest in an artificial intelligence (AI) innovation lab.</p>\n<p>Eli Lilly CFO and executive vice president Lucas Montarce joins Market Catalysts host <a data-i13n=\"cpos:3;pos:1\" href=\"https://finance.yahoo.com/author/julie-hyman/\">Julie Hyman</a> to discuss how the pharmaceutical company is leveraging AI to expedite drug discovery.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more <a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/videos/series/market-catalysts/\">Market Catalysts</a>.</p>",
        "summary": "Eli Lilly (LLY) is teaming up with Nvidia (NVDA) to invest in an artificial intelligence (AI) innovation lab. Eli Lilly CFO and executive vice president Lucas Montarce joins Market Catalysts host Julie Hyman to discuss how the pharmaceutical company is leveraging AI to expedite drug discovery. To watch more expert insights and analysis on the latest market action, check out more Market Catalysts.",
        "pubDate": "2026-01-13T17:12:33Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-01/bae95c00-f09e-11f0-9ea7-39c1867d4be4",
          "originalWidth": 3347,
          "originalHeight": 1881,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/U7_6xVHEODCTiHx9byYpzA--~B/aD0xODgxO3c9MzM0NzthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-01/bae95c00-f09e-11f0-9ea7-39c1867d4be4.cf.webp",
              "width": 3347,
              "height": 1881,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UGXR.HVlmIpZJUDifLSq0A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-01/bae95c00-f09e-11f0-9ea7-39c1867d4be4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/eli-lilly-teams-nvidia-ai-171233886.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/eli-lilly-teams-nvidia-ai-171233886.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T17:07:22+00:00",
    "headline": "Top Midday Stories: Boeing Q4 Deliveries Rise; L3Harris $1 Billion Investment; JPMorgan Chase Q4 Earnings Fall",
    "summary": "The Dow Jones Industrial Average was down, the S&P 500 was roughly flat and the Nasdaq Composite was",
    "url": "https://finance.yahoo.com/news/top-midday-stories-boeing-q4-170722462.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "2005c2c6-f54b-337b-b868-a86c33255610",
      "content": {
        "id": "2005c2c6-f54b-337b-b868-a86c33255610",
        "contentType": "STORY",
        "title": "Top Midday Stories: Boeing Q4 Deliveries Rise; L3Harris $1 Billion Investment; JPMorgan Chase Q4 Earnings Fall",
        "description": "",
        "summary": "The Dow Jones Industrial Average was down, the S&P 500 was roughly flat and the Nasdaq Composite was",
        "pubDate": "2026-01-13T17:07:22Z",
        "displayTime": "2026-01-13T17:07:22Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-boeing-q4-170722462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/top-midday-stories-boeing-q4-170722462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BA"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T17:06:57+00:00",
    "headline": "Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point",
    "summary": "Dow Jones retail giant Amazon is approaching a fresh buy point, as the stock market holds near record highs.",
    "url": "https://www.investors.com/stock-lists/stocks-near-a-buy-zone/dow-jones-amazon-amzn-stock-buy-point-eli-lilly/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "dd85d85e-a427-3202-b9a5-5e6575f4692d",
      "content": {
        "id": "dd85d85e-a427-3202-b9a5-5e6575f4692d",
        "contentType": "STORY",
        "title": "Dow Jones Retail Giant Amazon Stock Eyes Latest Buy Point",
        "description": "",
        "summary": "Dow Jones retail giant Amazon is approaching a fresh buy point, as the stock market holds near record highs.",
        "pubDate": "2026-01-13T17:06:57Z",
        "displayTime": "2026-01-13T17:06:57Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/dd85d85e-a427-3202-b9a5-5e6575f4692d/dow-jones-retail-giant-amazon.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/664f1b4ff42de09eb4726407140edff8",
          "originalWidth": 1065,
          "originalHeight": 600,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RyDJgFdP6QS2pSdJ8laXug--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/664f1b4ff42de09eb4726407140edff8.cf.webp",
              "width": 1065,
              "height": 600,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dT1m6alxVkpqVofB7XlRjw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/664f1b4ff42de09eb4726407140edff8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/stock-lists/stocks-near-a-buy-zone/dow-jones-amazon-amzn-stock-buy-point-eli-lilly/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "SN"
            },
            {
              "symbol": "^DJI"
            },
            {
              "symbol": "IDXX"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "OPAI.PVT"
            },
            {
              "symbol": "GOOG"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T15:32:00+00:00",
    "headline": "The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Lam Research and Ampco-Pittsburgh",
    "summary": "Microsoft headlines Zacks' Analyst Blog as strong cloud, AI, and semiconductor trends shape outlooks across tech and healthcare.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-microsoft-153200387.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f8a8aee8-fae3-32e0-a6e5-5aa2a369b947",
      "content": {
        "id": "f8a8aee8-fae3-32e0-a6e5-5aa2a369b947",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Lam Research and Ampco-Pittsburgh",
        "description": "",
        "summary": "Microsoft headlines Zacks' Analyst Blog as strong cloud, AI, and semiconductor trends shape outlooks across tech and healthcare.",
        "pubDate": "2026-01-13T15:32:00Z",
        "displayTime": "2026-01-13T15:32:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d091b3e912681bbeabff8c176ea70a1",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/j_em.9ncGoJjUS4ORBdaZw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d091b3e912681bbeabff8c176ea70a1.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mvTEQT49jmd3kudPY9tlfw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d091b3e912681bbeabff8c176ea70a1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-microsoft-153200387.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-microsoft-153200387.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "LRCX"
            },
            {
              "symbol": "AP"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T14:58:00+00:00",
    "headline": "Novo Nordisk Soars 19% in a Month: How Should You Play the Stock?",
    "summary": "NVO jumps nearly 19% in a month primarily on the FDA approval and launch of oral Wegovy, the first GLP-1 pill for obesity and cardiovascular risk reduction.",
    "url": "https://finance.yahoo.com/news/novo-nordisk-soars-19-month-145800412.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "0da08145-74a1-3ba3-aefc-6e1aff92ba3d",
      "content": {
        "id": "0da08145-74a1-3ba3-aefc-6e1aff92ba3d",
        "contentType": "STORY",
        "title": "Novo Nordisk Soars 19% in a Month: How Should You Play the Stock?",
        "description": "",
        "summary": "NVO jumps nearly 19% in a month primarily on the FDA approval and launch of oral Wegovy, the first GLP-1 pill for obesity and cardiovascular risk reduction.",
        "pubDate": "2026-01-13T14:58:00Z",
        "displayTime": "2026-01-13T14:58:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OpV4giEb4QjgN71LPYFzIw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QcLiFahMpkHBfBp4mOYpEQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/723b414aa10600faf58f7a232ec73364.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-soars-19-month-145800412.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/novo-nordisk-soars-19-month-145800412.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "NONOF"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-13T18:41:35+00:00",
    "headline": "Sector Update: Health Care Stocks Decline Tuesday Afternoon",
    "summary": "Health care stocks were lower Tuesday afternoon, with the NYSE Health Care Index down 0.6% and the S",
    "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-184135242.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "3af29da6-facb-33e7-9e81-5ab6ba98781f",
      "content": {
        "id": "3af29da6-facb-33e7-9e81-5ab6ba98781f",
        "contentType": "STORY",
        "title": "Sector Update: Health Care Stocks Decline Tuesday Afternoon",
        "description": "",
        "summary": "Health care stocks were lower Tuesday afternoon, with the NYSE Health Care Index down 0.6% and the S",
        "pubDate": "2026-01-13T18:41:35Z",
        "displayTime": "2026-01-13T18:41:35Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-184135242.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sector-health-care-stocks-decline-184135242.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "XLV"
            },
            {
              "symbol": "NVO"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]